107 related articles for article (PubMed ID: 3120645)
1. [Study on the preoperative adjuvant therapy of cancer--relation between serum and tumor tissue levels of UFT and OK-432 after administration, and skin reactions to Su-polysaccharide (Su-Ps)].
Kumazawa H; Ishikawa M; Rei S; Saito H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3329-35. PubMed ID: 3120645
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis].
Horiuchi M; Sato K; Nakarai I; Shinoda A
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):468-74. PubMed ID: 2181937
[TBL] [Abstract][Full Text] [Related]
3. [Tissue and serum levels of 5-FU in the patients with head and neck malignant tumors--influence of a streptococcal preparation OK-432].
Suzuki K; Itaya S; Tsuge I; Matsuda T; Motai H; Kobayashi T; Shimada J; Baba S
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1349-54. PubMed ID: 8346933
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
[TBL] [Abstract][Full Text] [Related]
5. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
[TBL] [Abstract][Full Text] [Related]
6. [Effects of OK-432 on UFT activation].
Yamamoto Y; Amano T; Imada T; Tamura S; Abe M; Matsumoto A
Gan No Rinsho; 1988 May; 34(6):749-54. PubMed ID: 3132564
[TBL] [Abstract][Full Text] [Related]
7. [Influence of OK-432 on intratumor 5-fluorouracil concentration in cases given UFT].
Sinmyo K; Hosoi H; Suwa H; Kitagawa M; Yamaguchi K; Susaki H
Gan To Kagaku Ryoho; 1989 May; 16(5):2051-7. PubMed ID: 2499267
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy with UFT or UFT with OK-432 to patients with gastric and colorectal cancer. Kanto Adjuvant Study Group].
Konishi T; Idezuki Y; Watanabe H; Haga S; Ushirokouji Y; Shinohara K; Shibusawa M; Bandai Y; Hiraishi M; Murata N; Yabe K; Yamamura T; Yumoto S; Gunji A; Nishigaki M
Gan To Kagaku Ryoho; 1998 May; 25(6):887-900. PubMed ID: 9617328
[TBL] [Abstract][Full Text] [Related]
9. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
Nakarai I; Rikitake H; Koga T; Hayashi A; Harada Y; Takamoto M; Ishibashi T; Shinoda A; Sagawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of a skin test (SU-PS) for immune responses in patients with gastrointestinal cancer treated with OK-432].
Miyamoto Y; Takeshita M; Izuo M
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3229-35. PubMed ID: 3777960
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
Takeyama M; Honjoh M; Ohnishi N; Ishikawa Y; Sakaguchi H; Hanai J
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1953-9. PubMed ID: 8215468
[TBL] [Abstract][Full Text] [Related]
12. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207].
Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H
Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831
[TBL] [Abstract][Full Text] [Related]
13. [5-FU concentration in the blood and tissue of patients with gastric and colorectal cancer after administration of UFT or tegafur].
Arima S; Futami K; Shigeta M; Kinashi M; Shimura H
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2618-24. PubMed ID: 3090940
[TBL] [Abstract][Full Text] [Related]
14. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
15. [Effects of preoperative administration of UFT in gastrointestinal cancer].
Sato Y; Une Y; Nagabuchi E; Matsuoka S; Kagaya H; Miyata S; Yakura Y; Uchino J
Gan To Kagaku Ryoho; 1986 Feb; 13(2):337-41. PubMed ID: 3080966
[TBL] [Abstract][Full Text] [Related]
16. [UFT concentration in various tissues from cancer patients].
Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
[TBL] [Abstract][Full Text] [Related]
17. [5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Masuda F; Suzuki M; Ohnishi T; Nakada J; Mori Y; Iizuka N; Machida T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):320-4. PubMed ID: 3918507
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapy of terminal-stage malignant tumors with the immunopotentiator OK-432--a comparison between SU-PS test-responder and -nonresponder patients].
Yagi Y; Yagi S; Ichiki H
Gan No Rinsho; 1987 Jun; 33(7):815-21. PubMed ID: 3302349
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on the reaction of the skin to various doses of Su-polysaccharide in cancer patients].
Sato M; Sakai K; Kimura S; Tamaki Y; Kiyasu Y; Joko Y; Ogoshi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):245-9. PubMed ID: 3970550
[TBL] [Abstract][Full Text] [Related]
20. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT].
Koida T; Kimura M
Gan To Kagaku Ryoho; 1985 May; 12(5):1147-51. PubMed ID: 3922313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
